Skip to main content
Caplight Logo









1Drop Diagnostics

1Drop Diagnostics

Private
NeuchâtelHealthcare & Life Scienceshttps://www.1dropdx.com/

Last Round

Series A

Oct 31, 2018

Total Funding Raised

$4.67M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

1Drop Diagnostics is a life science company that develops and commercializes a portable medical diagnostic platform for point-of-care testing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine, Space Technology, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

point-of-care diagnosticsmicrofluidicsPOC testingportable diagnostic devicemultiplexed assaycompanion diagnosticslab-on-a-chipbiomarker analysiselectronic health recordEHRprecision medicinespace medicineremote diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

1Drop Diagnostics Comparables

Compare 1Drop Diagnostics with similar companies based on industry and business-model similarity.

1Drop Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Omini
83%
Vital Bio
82%
Chronus Health
81%

1Drop Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 31, 2018
GrantApr 25, 2017
AcceleratorFeb 25, 2016
GrantJun 26, 2015
GrantOct 20, 2014
Accelerator
May 22, 2014

Key People

Founding team and executive leadership

Joerg Z.

Co Founder, CTO

Founding Team

1Drop Diagnostics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 53% MoM, from 2.6K to 4K.

  • Oct 31, 2018

    $4.25M round led by Christian Wildmoser.

1Drop Diagnostics Filings

Explore SEC and related filing metadata, where available.

1Drop Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 1Drop Diagnostics's valuation, stock price, and market status.

Is 1Drop Diagnostics a public or private company?

1Drop Diagnostics is a private company.

What is the current stock price of 1Drop Diagnostics?

1Drop Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is 1Drop Diagnostics worth (valuation)?

Valuation information for 1Drop Diagnostics is not publicly available.

Can I buy 1Drop Diagnostics stock?

1Drop Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 1Drop Diagnostics's last funding round?

1Drop Diagnostics's most recent funding round was Series A on October 31, 2018.

Who are the main investors in 1Drop Diagnostics?

Key investors in 1Drop Diagnostics include Blackbox, ventureLAB.

Will 1Drop Diagnostics IPO soon?

No public IPO plans have been announced for 1Drop Diagnostics.

How can I track 1Drop Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 1Drop Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNeuchâtel
Employee Range4
Year Founded2012
Last FundingOct 31, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?